Skip to main content

Global Transcatheter Mitral Valve Replacement (TMVR) Market: Patient-Centric Solutions by 2030

 


The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast period. Major factors driving growth include increased prevalence of mitral valve diseases, growing preferences for minimally invasive procedures, advancements in TMVR technology, growing geriatric population, increasing clinical trials & regulatory approvals for TMVR devices, and favorable reimbursement policies for TMVR procedures.

Transcatheter Mitral Valve Replacement (TMVR) is a minimally invasive procedure designed to replace a damaged or diseased mitral valve in the heart. As one of the four heart valves regulating blood flow between chambers, the mitral valve plays a crucial role in circulation. When it becomes compromised, it can lead to blood leakage into the lungs, causing symptoms such as shortness of breath, fatigue, and fluid buildup.

During TMVR, a new valve is delivered through a catheter, typically inserted via an artery in the groin or chest. Using advanced imaging techniques like X-ray or echocardiography, the catheter is carefully guided to the heart. Once positioned, the new valve is expanded and secured within the existing valve structure, restoring proper blood flow. TMVR can be performed using two main techniques:

  • Native Valve Replacement: An investigational approach that directly replaces the patient’s original mitral valve
  • Valve-in-Valve Replacement: A method used to implant a new valve within a failing prosthetic valve or a previously placed annuloplasty ring from prior surgery

🔗 Want deeper insights? Download the sample report here:
https://meditechinsights.com/transcatheter-mitral-valve-replacement-tmvr-market/request-sample/

The increasing prevalence of mitral valve diseases drives market growth

The increasing prevalence of mitral valve diseases, particularly mitral regurgitation (MR) and mitral stenosis (MS), is becoming a significant global health concern. Factors such as an aging population, rising incidences of cardiovascular diseases, and lifestyle-related conditions like hypertension and obesity contribute to the growing burden of these disorders. A 2023 ScienceDirect article states that mitral regurgitation, the most prevalent valvular heart disease, impacts approximately 2% of the general population and up to 10% of individuals over 75, frequently resulting in heart failure if untreated.  Additionally, mitral stenosis remains a major issue in developing regions due to persistent cases of rheumatic heart disease. Many of these conditions progress silently, resulting in late-stage diagnosis and the need for advanced interventions. As surgical treatments pose high risks for elderly and comorbid patients, the demand for minimally invasive solutions such as transcatheter mitral valve replacement (TMVR) is rising, driving innovation and growth in the global TMVR market.

Growing preference for minimally invasive procedures in TMVR fuels its demand

The growing preference for minimally invasive procedures in transcatheter mitral valve replacement (TMVR) is transforming the landscape of mitral valve disease treatment. Unlike traditional open-heart surgery, which involves significant risks, long recovery times, and potential complications, TMVR offers a less invasive alternative with reduced hospital stays and faster patient recovery. Advancements in catheter-based technology, imaging guidance, and procedural techniques have made TMVR a viable option for high-risk patients who are ineligible for conventional surgery. Additionally, the increasing awareness of patient-centric care and the demand for quicker, less painful treatments are driving the adoption of minimally invasive TMVR. As healthcare systems prioritize cost-effective solutions with better clinical outcomes, the shift toward minimally invasive interventions is expected to accelerate, further boosting the growth of the TMVR market.

Competitive Landscape Analysis

The global transcatheter mitral valve replacement (TMVR) market is marked by the presence of established and emerging market players such as Abbott Laboratories; Edwards Lifesciences; Medtronic plc; Boston Scientific Corporation; LivaNova; Cardiac Dimensions; NeoChord, Inc.; Opus Medical Therapies, LLC; HighLife Medical; and Neovasc; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.

Get PDF Report for Competitive Analysis:
https://meditechinsights.com/transcatheter-mitral-valve-replacement-tmvr-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global transcatheter mitral valve replacement (TMVR) market at the regional- and country level from 2023 to 2030. The report further segments the market based on product type, indication, and end user.

  • Market Size & Forecast (2023-2030), By Product Type, USD Million
    • Mechanical Valves
    • Bioprosthetic/Tissue Valves
  • Market Size & Forecast (2023-2030), By Indication, USD Million
    • Functional Mitral Regurgitation (FMR)
    • Degenerative Mitral Regurgitation (DMR)
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Cardiac Catheterization Laboratories
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more